The book-built issue of Rs 63.00 crore is the Brooks Labs IPO. The bidding for the Brooks Labs IPO began on August 16, 2011, and it concluded on August 18, 2011. On September 5, 2011, the shares went on sale on the BSE and NSE. The pricing range for Brooks Labs’ IPO is ₹90 to ₹100 per share. An application must have a minimum lot size of 60 shares. Retail investors are obliged to invest a minimum of ₹6,000.
Pharmaceutical Contract Research & Manufacturing is the business that Brooks Laboratories Ltd. operates in. The company was founded in 2002. The company produces a wide range of goods for the parental section’s critical care market, including tablets, ampoules, liquid vials, dry syrups, and injectables for beta-lactamase, cephalosporin, and general dry powder. A production facility for Brooks Labs is located in Baddi, Himachal Pradesh. The company employs a top-notch team to create novel compounds for injectables and goods based on clavulanic
acid, and their advanced infrastructure for research and development supports their efforts. Brooks Laboratories is an ISO 9000-2008 and WHO-GMP-accredited business. In recent years, there has been substantial progress in the infrastructure, technology, and product range of the Indian pharmaceutical business. With 1.5% to 2% of global output by value and 8% to 10% of global production by volume, the nation currently holds one of the top four positions in the globe.
Brooks Labs IPO Details
|IPO Date||August 16, 2011 to August 18, 2011|
|Listing Date||September 5, 2011|
|Face Value||₹10 per share|
|Price Band||₹90 to ₹100 per share|
|Lot Size||60 Shares|
|Total Issue Size||6,300,000 shares
(aggregating up to ₹63.00 Cr)
|Issue Type||Book Built Issue IPO|
|Listing At||BSE, NSE|
Brooks Labs IPO Lot Size
Brooks Labs IPO Reservation
|Investor Category||Shares Offered||Maximum Allottees|
|Anchor Investor Shares Offered||–||NA|
|QIB Shares Offered||3,500,000 (50.00%)||NA|
|NII (HNI) Shares Offered||1,050,000 (15.00%)|
|Retail Shares Offered||2,450,000 (35.00%)||40,833|
|Total Shares Offered||7,000,000 (100%)|
Brooks Labs Company Financials
|Profit After Tax (PAT)||688.82||519.57||296.06||358.01||112.49|
Objects of the Issue (Brooks Labs IPO Objectives)
The objects of the issue are:
- To set up our new manufacturing unit at JB SEZ Pvt Ltd., Panoli, Gujarat, for the manufacturing of various pharmaceutical formulations.
- To meet the long-term working capital requirement
- To meet General Corporate Purpose and
- To meet issue expenses and listing of shares on stock exchanges.
Brooks Labs IPO Listing Details
|Listing Date||September 5, 2011|
|BSE Script Code||533543|
|Final Issue Price||₹100 per share|
Brooks Labs Listing Day Trading Information
|Final Issue Price||₹100.00||₹100.00|
Brooks Labs IPO FAQs
Q1. What is the Brooks Labs IPO?
Ans. Brooks Labs IPO is a main-board IPO of 6,300,000 equity shares with a face value of ₹10, aggregating up to ₹63.00 crore. The issue is priced at ₹90 to ₹100 per share. The minimum order quantity is 60 shares. The IPO opens on August 16, 2011, and closes on August 18, 2011.
Q2. When will Brooks Labs IPO open?
Ans. The Brooks Labs IPO opens on August 16, 2011 and closes on August 18, 2011.
Q3. What is the size of the Brooks Labs IPO?
Ans. Brooks Labs IPO lot size is 60 shares, and the minimum amount required is ₹6,000.
Q4. When is the Brooks Labs IPO listing date?
Ans. The Brooks Labs IPO listing date is on September 5, 2011.